Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of PDL2-IgGFc fusion protein in inhibiting severe malaria morbidity

A fusion protein and PD-1 technology, applied in the direction of application, fusion polypeptide, peptide/protein composition, etc., can solve problems that have not been fully elucidated, and achieve the effect of prolonging survival time and alleviating cerebral malaria

Inactive Publication Date: 2016-08-31
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But up to now, the specific mechanism of blood-brain barrier damage in cerebral malaria has not been fully elucidated.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of PDL2-IgGFc fusion protein in inhibiting severe malaria morbidity
  • Application of PDL2-IgGFc fusion protein in inhibiting severe malaria morbidity
  • Application of PDL2-IgGFc fusion protein in inhibiting severe malaria morbidity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0032] The present invention will be further described in detail below in conjunction with specific embodiments, which are explanations of the present invention rather than limitations.

[0033] The pre-experimental results of the present invention in the mouse model of PD-1 gene knockout cerebral malaria have proved that the regulation of the PD-1 / PD-L pathway has a significant impact on the outcome of cerebral malaria, which makes it possible to properly up-regulate PD- The 1 / PD-L pathway makes possible an immunotherapy strategy to alleviate the symptoms of severe malaria such as cerebral malaria.

[0034] Based on the above research results, the present invention puts forward the following hypothesis: if vascular endothelial cells can specifically overexpress PD-L ligands in the mouse cerebral malaria model, then CD8+ CTL cells will receive more PD from endothelial cells. -L signal, more PD-1 receptors on the surface will be activated, thereby transducing more inhibitory si...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Titeraaaaaaaaaa
Titeraaaaaaaaaa
Titeraaaaaaaaaa
Login to View More

Abstract

The invention discloses application of PDL2-IgGFc fusion protein in inhibiting severe malaria morbidity and belongs to the technical field of anti-malarial drugs. A fusion gene of a PDL2 molecule extracellular fragment and an IgG molecule Fc fragment is structured, the fusion gene is structured into adenovirus or expressed in vitro, and the fusion protein is expressed successfully by Western Blot method validation. In in-vitro cell tests, the fusion protein can significantly inhibit ConA induced CD8+T cell activation, meanwhile, in mice in-vivo tests, recombinant adenovirus of tail vein injection expressed PDL2-IgGFc fusion protein can obviously relieve occurrence of cerebral malaria caused by plasmodium berghei Anka strain infection, and survival time of mice is prolonged. The PDL2-IgGFc fusion protein has the effect of inhibiting occurrence of severe malaria, and the inhibiting effect is related to that the PDL2-IgGFc fusion protein can inhibit activation of CD8+T cells. The fusion protein provides a novel drug choice for clinical treatment of severe malaria such as cerebral malaria.

Description

technical field [0001] The invention belongs to the technical field of preparation of antimalarial drugs, and in particular relates to the application of PDL2-IgGFc fusion protein to inhibit severe malaria. Background technique [0002] Malaria is one of the most prevalent infectious diseases in the world, threatening 3.2 billion people worldwide. In 2014, there were approximately 214 million malaria cases and 440,000 deaths worldwide. There are five main species of Plasmodium that infect humans. Severe malaria is usually caused by Plasmodium falciparum. Among them, cerebral malaria is one of the most serious severe malaria. Studies have pointed out that even after active treatment, its mortality rate can still be as high as 18%. Most children with cerebral malaria die within 1-2 days after the onset of central nervous system symptoms, and even surviving cases often have neurological sequelae. Most studies believe that cerebral malaria is caused by the adhesion of erythrocy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N15/62C12N15/861A61K38/17A61P33/06
CPCA61K38/00C07K14/435C07K2319/30Y02A50/30
Inventor 赵亚王军沈燕李英辉梁姣黄豫晓
Owner FOURTH MILITARY MEDICAL UNIVERSITY